The New Viagra?

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

May 2 (Bloomberg) -- Bloomberg's Josh Lipton reports that Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn demand for the treatments could lead to overuse with deadly side effects. In what may become one of the most sought after sex enhancement treatments since the introduction of Viagra 14 years ago. He speaks on Bloomberg Television's "Inside Track." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change